Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Rimiducid

EU orphan designation number: EU/3/16/1666   
Active ingredient: Rimiducid
Indication: Treatment of graft-versus-host disease
Sponsor: Bellicum Pharma Limited
Cooley (UK) LLp Dashwood, 69 Broad Street, London EC2M 1QS, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/06/2016 Orphan designation EMA/OD/017/16 (2016)3422 of 30/05/2016
10/05/2017 Transfer of orphan designation EMA/OD/017/16/T/01 (2017)3189 of 08/05/2017